Left ventricular pseudoaneurysm (LVP) is a rare but potentially life-threatening complication of myocardial free-wall rupture. We describe an intriguing CASE of incidental LVP detection in an elderly patient without typical cardiac symptoms. Read our CASE report: bit.ly/3J3my2o

💬 Editorial: IMPROVE-multi and PRETREAT randomized trials found that tailoring intraoperative blood pressure targets to preoperative values or individual risk did not reduce rates of acute kidney injury, myocardial injury, cardiac arrest, death, or postoperative disability compared with conventional MAP thresholds. #ANES25 https://ja.ma/4h3lND7

🔎 Early detection saves lives. On this #WorldHeartDay, join Dr. Geoff Barnes in the WTD #CardiocCorner as he highlights guideline-based strategies for diagnosing cardiac thrombosis. 📺 Watch now and refresh your approach to thrombosis detection and diagnosis! For more resources, click here: worldthrombosisday.org #WorldThrombosisDay #WTDay25

Venous thromboembolism (VTE) –including deep vein thrombosis (DVT) and pulmonary embolism (PE) –is a serious and potentially fatal condition. It remains one of the most common –and most preventable –causes of hospital death, with many patients still going without adequate prevention. Yet with the right strategies in place, we can help caregivers prevent the preventable. Explore Arjo’s approach to safer, smarter VTE prevention: https://lnkd.in/d7rf_pJW #VTEAwareness #EmpoweringMovement #ArjoGlobal #VTE

Venous thromboembolism (VTE) –including deep vein thrombosis (DVT) and pulmonary embolism (PE) –is a serious and potentially fatal condition. It remains one of the most common –and most preventable –causes of hospital death, with many patients still going without adequate prevention. Yet with the right strategies in place, we can help caregivers prevent the preventable. Explore Arjo’s approach to safer, smarter VTE prevention: https://lnkd.in/dFAu2XdK #VTEAwareness #EmpoweringMovement #ArjoAustralia #VTE

In an insightful study with systematic OCT/OFDI use, IVL plus atherectomy resulted in ⬆️ procedural time and ⬆️ risk of myocardial injury for PCI of calcific lesions, with IVL alone being sufficient in lesions where device delivery is feasible https://lnkd.in/d86G_xSA

From JAMA: Among patients with insertable cardiac monitors after CABG, the cumulative 1-year incidence of new-onset AF was 48%, yet median AF burden after 30 days was nearly zero. #EACTS2025 https://ja.ma/46IuJKI

Among patients with insertable cardiac monitors after CABG, the cumulative 1-year incidence of new-onset AF was 48%, yet median AF burden after 30 days was nearly zero. #EACTS2025 https://ja.ma/4nGo0Xt

Sepsis is a silent killer—and for cardiac patients, the risks are even higher. This carousel highlights why heart patients are especially vulnerable, how early signs can be missed, and what timely action can do to save lives.

Venous thromboembolism (VTE) –including deep vein thrombosis (DVT) and pulmonary embolism (PE) –is a serious and potentially fatal condition. It remains one of the most common –and most preventable –causes of hospital death, with many patients still going without adequate prevention. Yet with the right strategies in place, we can help caregivers prevent the preventable. October 13th is World Thrombosis Day. Be part of the movement for a safer, healthier future! Explore Arjo’s approach to safer, smarter VTE prevention: https://lnkd.in/dYV4AF5q #VTEAwareness #EmpoweringMovement #ArjoIreland #VTE